http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9404922-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
filingDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b2c8b156df2293d5296113ab54f8164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_661a57cd38cb0ed173a75365c7c321f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d316c39b70b414a025f873a756085dd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af24a15b4efd3f90262efb26e0c7b48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43d99b9907d558612198e360dbb9486a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f692cf0ae2724a178589db6acfde537b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5bf17c26adc1018d6aa8694014922c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e9c6fc785bc6f6abc9a572bd4660f1
publicationDate 1994-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9404922-A1
titleOfInvention Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections
abstract A means for determining the effectiveness of interferon therapy in individuals who are infected with Hepatitis C Virus (HCV) and are receiving such therapy. Monitoring the level of anti-HCV IgM and/or anti-GOR IgG provide means for establishing whether or not the infected patient is responding to interferon therapy; such monitoring is especially useful for patients diagnosed with chronic acute HCV infections.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005050214-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5447650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005050214-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9641195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076085-B2
priorityDate 1992-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5191064-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17942975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128596011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127575215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID640842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129920816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57461963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129113970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232806233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415400

Total number of triples: 54.